Physician profile
Hemikaa Devakumar
NPI 1801213731
$4,370.71
in general payments reported to CMS, 2019-2025
23 companies · $815 in 2025
The $815 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $389 · 2021: $361 · 2022: $1,019 · 2023: $549 · 2024: $402 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,666.63 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $2,039.39 | 2019-2025 | Desara |
| Astellas Pharma US INC | $556.38 | 2019-2023 | |
| Medtronic, INC. | $473.22 | 2022-2025 | Altaviva |
| Femselect INC. | $230.59 | 2023-2025 | Enplace |
| Abbvie INC. | $130.07 | 2022-2025 | |
| Coloplast Corp | $129.09 | 2019-2024 | |
| 180 Medical, INC. | $119.46 | 2019-2023 | |
| Coopersurgical, INC. | $119.17 | 2025 | Onetrac Lx |
| Boston Scientific Corporation | $93.54 | 2020-2022 | |
| Axonics, INC. | $85.41 | 2022 | |
| Urovant Sciences INC | $54.68 | 2022 | |
| Janssen Biotech, INC. | $50.50 | 2025 | Erleada |
| Pfizer INC. | $42.35 | 2019 | |
| Rochester Medical Corporation | $35.08 | 2021-2022 | |
| Olympus America INC. | $35.08 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $34.90 | 2020 | |
| Tolmar, INC. | $28.37 | 2023 | |
| Hologic Sales and Service, LLC | $24.21 | 2024 | Aptima |
| Dendreon Pharmaceuticals LLC | $21.85 | 2025 | Provenge |
| Inspire Medical Systems, INC. | $18.63 | 2023 | Inspire |
| Millicent US INC | $18.44 | 2024 | Intrarosa |
| Sumitomo Pharma America, INC. | $15.20 | 2023 | Gemtesa |
| Allergan, INC. | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemikaa Devakumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.